Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

A rapid point-of-care assay accurately measures vitamin D

Source: Article title. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Laboratory / cell research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

It is designed for in vitro quantitative determination of total 25(OH)D3 using serum samples.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

A rapid point-of-care assay accurately measures vitamin D

Study design awaiting verification · Journal of Endocrinological Investigation · 2021

Original publication title

A rapid point-of-care assay accurately measures vitamin D

K. Albrecht; J. Lotz; L. Frommer; K. J. Lackner; G. J. Kahaly

© The Author(s) 2021

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This novel, innovative, and controlled study indicates that the evaluated rapid point of care VitD assay is reliable, accurate, and suited for clinical practice.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

Vitamin D (VitD) is a pleiotropic hormone with effects on a multitude of systems and metabolic pathways. Consequently, the relevance of a sufficiently high VitD serum level becomes self-evident.

Source: Purpose

Abstract: What methods does the paper describe?

A rapid immunofluorescence assay designed for the point-of-care measurement of serum VitD3 solely was tested. Inter: and intra-assay validation, double testing and result comparison with a standardized laboratory method were performed.

Source: Methods

Abstract: Results

An overall linear correlation of r = 0.89 (Pearson, 95% CI 0.88 to 0.92, p < 0.01) between the point of care and the conventional reference assay was registered. Accuracy and precision were of special interest at cut-points (10 ng/ml [mean deviation 1.7 ng/ml, SD 1.98 ng/ml, SE 0.16 ng/ml], 12 ng/ml [MD 0.41, SD 1.89, SE 0.19] and 30 ng/ml [MD − 1.11, SD 3.89, SE 0.35]). Only a slight deviation was detected between the two assays when using fresh (r = 0.91, 95% CI 0.86 to 0.94, p < 0.01) and frozen serum samples (r = 0.86, 0.82 to 0.89, p < 0.01).

Results remained steady when samples were frozen several times. Inter: and intra-assay validation according to the CLSI protocol as well as multiuser testing showed stable results.

Source: Results

Abstract: Conclusion

This novel, innovative, and controlled study indicates that the evaluated rapid point of care VitD assay is reliable, accurate, and suited for clinical practice.

Source: Conclusion
Authors’ abstract

Purpose

Vitamin D (VitD) is a pleiotropic hormone with effects on a multitude of systems and metabolic pathways. Consequently, the relevance of a sufficiently high VitD serum level becomes self-evident.

Methods

A rapid immunofluorescence assay designed for the point-of-care measurement of serum VitD3 solely was tested. Inter: and intra-assay validation, double testing and result comparison with a standardized laboratory method were performed.

Results

An overall linear correlation of r = 0.89 (Pearson, 95% CI 0.88 to 0.92, p < 0.01) between the point of care and the conventional reference assay was registered. Accuracy and precision were of special interest at cut-points (10 ng/ml [mean deviation 1.7 ng/ml, SD 1.98 ng/ml, SE 0.16 ng/ml], 12 ng/ml [MD 0.41, SD 1.89, SE 0.19] and 30 ng/ml [MD − 1.11, SD 3.89, SE 0.35]). Only a slight deviation was detected between the two assays when using fresh (r = 0.91, 95% CI 0.86 to 0.94, p < 0.01) and frozen serum samples (r = 0.86, 0.82 to 0.89, p < 0.01).

Results remained steady when samples were frozen several times. Inter: and intra-assay validation according to the CLSI protocol as well as multiuser testing showed stable results.

Conclusion

This novel, innovative, and controlled study indicates that the evaluated rapid point of care VitD assay is reliable, accurate, and suited for clinical practice.

Publication and source details

Original title: A rapid point-of-care assay accurately measures vitamin D

K. Albrecht; J. Lotz; L. Frommer; K. J. Lackner; G. J. Kahaly

Journal of Endocrinological Investigation · 2021

© The Author(s) 2021https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Universitätsmedizin der Johannes Gutenberg-Universität Mainz (8974)

Open Access funding enabled and organized by Projekt DEAL.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T02:04:36.549824+00:00

DOI: 10.1007/s40618-021-01575-8 · PMC8502163